CA2173606A1 - Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains, methods of making same and products thereof - Google Patents

Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains, methods of making same and products thereof

Info

Publication number
CA2173606A1
CA2173606A1 CA002173606A CA2173606A CA2173606A1 CA 2173606 A1 CA2173606 A1 CA 2173606A1 CA 002173606 A CA002173606 A CA 002173606A CA 2173606 A CA2173606 A CA 2173606A CA 2173606 A1 CA2173606 A1 CA 2173606A1
Authority
CA
Canada
Prior art keywords
cholerae
plasmid
sequences
strain
avirulent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002173606A
Other languages
English (en)
French (fr)
Inventor
James B. Kaper
Myron M. Levine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland at Baltimore
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2173606A1 publication Critical patent/CA2173606A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002173606A 1993-10-08 1994-10-07 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains, methods of making same and products thereof Abandoned CA2173606A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13343893A 1993-10-08 1993-10-08
US13343993A 1993-10-08 1993-10-08
US08/133,438 1993-10-08
US08/133,439 1993-10-08

Publications (1)

Publication Number Publication Date
CA2173606A1 true CA2173606A1 (en) 1995-04-20

Family

ID=26831377

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002173606A Abandoned CA2173606A1 (en) 1993-10-08 1994-10-07 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains, methods of making same and products thereof

Country Status (8)

Country Link
EP (1) EP0722339A4 (ru)
JP (1) JP3379582B2 (ru)
KR (1) KR100348156B1 (ru)
CN (1) CN1104907C (ru)
AU (1) AU699912B2 (ru)
CA (1) CA2173606A1 (ru)
RU (1) RU2140981C1 (ru)
WO (1) WO1995010300A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0887403A3 (en) * 1997-06-27 2000-12-06 Chiron S.P.A. Attenuated Vibrio cholerae strains
EP0928831B1 (en) * 1997-12-10 2006-05-03 Council of Scientific and Industrial Research Cholera organisms, vaccines and preparation thereof
CN111826316A (zh) * 2020-07-28 2020-10-27 上海海洋大学 耐受重金属的非o1/o139型霍乱弧菌菌株及应用
CN111662855A (zh) * 2020-07-28 2020-09-15 上海海洋大学 耐受抗菌素和重金属的非o1/o139型霍乱弧菌菌株及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135862A (en) * 1983-03-04 1992-08-04 University Of Maryland Method of isolating restriction fragment deletions in vibrio cholerae, products thereof
ES2095322T3 (es) * 1990-06-05 1997-02-16 Univ Maryland Procedimiento para aislar mutantes de delecion vibrio cholerae y cultivos que contienen vibrio cholerae.
PT672116E (pt) * 1992-07-06 2003-10-31 Harvard College Mutantes por supressao como vacinas contra a colera

Also Published As

Publication number Publication date
KR100348156B1 (ko) 2003-01-06
CN1142774A (zh) 1997-02-12
AU699912B2 (en) 1998-12-17
KR960704571A (ko) 1996-10-09
AU7971494A (en) 1995-05-04
JPH09504430A (ja) 1997-05-06
WO1995010300A1 (en) 1995-04-20
EP0722339A1 (en) 1996-07-24
CN1104907C (zh) 2003-04-09
JP3379582B2 (ja) 2003-02-24
RU2140981C1 (ru) 1999-11-10
EP0722339A4 (en) 2001-05-23

Similar Documents

Publication Publication Date Title
US5399494A (en) Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom
US5631010A (en) Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1
Butterton et al. Heterologous antigen expression in Vibrio cholerae vector strains
Homchampa et al. Molecular analysis of the aroA gene of Pasteurella multocida and vaccine potential of a constructed aroA mutant
AU763683B2 (en) Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccines
US4935364A (en) Method of isolating restriction fragment deletions in vibrio cholerae and products thereof
EP0119031B1 (en) Avirulent Vibrio Cholerae and methods for its production
Finn et al. Cell-associated hemagglutinin-deficient mutant of Vibrio cholerae
US5882653A (en) Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof
US5874088A (en) Deletion mutants of cholera vaccines expressing heterologous antigens
EP0485591B1 (en) Method for isolating deletion mutants of vibrio cholerae and cultures containing vibrio cholerae
AU699912B2 (en) (Vibrio cholerae) 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains and methods of making same
US5470729A (en) Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof
US5783196A (en) Gua mutants of shigella spp. and vaccines containing the same
WO2022078732A1 (en) High dose shigella vaccine preparation
Levine et al. 5.1 AN OVERVIEW OF CHOLERA PATHOGENESIS
JPH0630569B2 (ja) 遺伝子工学的に作成された無毒性Ｖｉｂｒｉｏ ｃｈｏｌｅｒａｅ、その用途及びその製造方法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead